Loss of ADAP1 / CentA1 Protects Against Autoimmune Demyelination
The FASEB Journal · 2025
DOI: 10.1096/fj.202403078r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Jonathan J Carver und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Microfilament Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Wooten Family Initiative for Brain Health Research, East Carolina University Startup Funds.
Abstract (Originalsprache)
ArfGAP with dual PH domain‐containing protein 1 (ADAP1), also known as Centaurin alpha‐1 (CentA1), is an actin‐binding protein highly expressed in the central nervous system (CNS) that was previously shown to regulate dendritic spine density and plasticity. In the context of disease, ADAP1/CentA1 has been linked to Alzheimer's disease (AD) pathogenesis, cancer progression, and human immunodeficiency virus (HIV) reactivation. Here, we document that ADAP1/CentA1 is also mechanistically involved in CNS autoimmunity. We show that ADAP1/CentA1 deficient mice exhibit partial resistance to developing experimental autoimmune encephalomyelitis (EAE), an in vivo disease model recapitulating several features of multiple sclerosis (MS) pathogenesis. MS is a chronic autoimmune disorder of the CNS characterized by focal immune cell infiltration, demyelination, and axonal injury. Its etiology is still elusive, but genetic and environmental factors contribute to disease risk. By combining detailed immunophenotyping and single‐cell RNA sequencing (scRNA‐seq), we demonstrate that ADAP1/CentA1 is necessary for mounting a sufficient autoimmune response for EAE initiation and progression. In particular, the current study highlights that ADAP1/CentA1 expression in the immune system mainly targets the functioning of regulatory T cells (Tregs), monocytes, and natural killer (NK) cells. In summary, our study defines a novel function for ADAP/CentA1 outside of the CNS and helps elucidate the early molecular events taking place in the peripheral immune system in response to encephalitogenic challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomy and Cell Biology, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
- Department of Physical Therapy, College of Allied Health Sciences, East Carolina University, Greenville, North Carolina, USA.
- Center for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Pathology and Laboratory Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina, USA.
ORCID-Profile: Alessandro Didonna
Förderung
- The Wooten Family Initiative for Brain Health Research
- East Carolina University Startup Funds
Zitieren
APA
Carver, J. J., Bunner, W. P., Denbrock, R. R., Yin, C., Huang, W., Szatmari, E. M., & Didonna, A. (2025). Loss of ADAP1 / CentA1 Protects Against Autoimmune Demyelination. The FASEB Journal. https://doi.org/10.1096/fj.202403078r
Vancouver
Carver JJ, Bunner WP, Denbrock RR, Yin C, Huang W, Szatmari EM, et al. Loss of ADAP1 / CentA1 Protects Against Autoimmune Demyelination. The FASEB Journal. 2025. doi:10.1096/fj.202403078r
BibTeX
@article{Carver2025,
author = {Carver, Jonathan J and Bunner, Wyatt P and Denbrock, Rachael R and Yin, Changhong and Huang, Weihua and Szatmari, Erzsebet M and Didonna, Alessandro},
title = {Loss of ADAP1 / CentA1 Protects Against Autoimmune Demyelination},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202403078r}
}
EUVIMED